Boston Scientific Corporation (NYSE:BSX) has agreed to acquire Axonics Inc (NASDAQ: AXNX) for $71 in cash per share, representing an enterprise value of approximately $3.4 billion and an equity value ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel ...

Medical device giant Boston Scientific announced a $3.7 billion deal on Monday to augment its urology portfolio. The company is acquiring Axonics, a maker of neurostimulation devices that treat ...

Like Medtronic’s recently approved InterStim X, Axonics’ F15 sacral neuromodulation implant is designed to treat bladder and bowel dysfunction by stimulating the sacral nerve, but it outstrips its ...

Axonics (NASDAQ: AXNX) specializes in making medical devices to treat bladder and bowel dysfunction. It's the type of therapy that may be embarrassing to some, but the company's financial performance ...

(Reuters) -Medical device maker Boston Scientific said on Monday it had agreed to buy Axonics Inc for $3.7 billion, gaining access to devices used to improve bladder function. The deal marks Boston ...

There were days, sometimes weeks, when Ashlee Lunsford barely left her bed. Pain pulsed through her body and her depression and anxiety rose as her health spiraled downward. The only thing getting ...